Japan
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
39.99%
|
Dec. 31, 2023 | USD 3.39 | -1.15% |
|
Japan |
|
2 |
38.01%
|
July 31, 2024 | USD 6.35 | -0.89% |
|
Japan |
|
3 |
33.61%
|
Dec. 31, 2023 | USD 4.79 | -1.78% |
|
Japan |
|
4 |
30.91%
|
Dec. 31, 2023 | USD 9.76 | -1.43% |
|
Japan |
|
5 |
29.56%
|
Sept. 30, 2024 | USD 2.93 | -1.24% |
|
Japan |
|
6 |
29.54%
|
Dec. 31, 2023 | USD 5.86 | -2.20% |
|
Japan |
|
7 |
27.00%
|
Dec. 31, 2023 | USD 43.39 | 5.16% |
|
Japan |
|
8 |
25.42%
|
Dec. 31, 2023 | USD 21.58 | 0.31% |
|
Japan |
|
9 |
24.93%
|
March 31, 2024 | USD 4.97 | -1.23% |
|
Japan |
|
10 |
21.29%
|
June 30, 2024 | USD 8.27 | -1.43% |
|
Japan |
|
11 |
20.54%
|
Dec. 31, 2023 | USD 3.77 | -0.24% |
|
Japan |
|
12 |
20.23%
|
March 31, 2024 | USD 10.39 | -0.80% |
|
Japan |
|
13 |
19.93%
|
Oct. 31, 2024 | USD 76.41 | -0.92% |
|
Japan |
|
14 |
19.87%
|
March 31, 2024 | USD 12.31 | 0.15% |
|
Japan |
|
15 |
19.29%
|
Oct. 31, 2023 | USD 5.47 | -1.74% |
|
Japan |
|
16 |
19.18%
|
March 31, 2024 | USD 10.75 | -2.71% |
|
Japan |
|
17 |
18.37%
|
Sept. 30, 2024 | USD 3.00 | -0.80% |
|
Japan |
|
18 |
18.25%
|
July 31, 2024 | USD 2.76 | -3.94% |
|
Japan |
|
19 |
18.13%
|
March 31, 2024 | USD 8.69 | -1.39% |
|
Japan |
|
20 |
17.87%
|
March 31, 2024 | USD 9.19 | -0.31% |
|
Japan |
|
21 |
17.10%
|
March 31, 2024 | USD 3.38 | -1.89% |
|
Japan |
|
22 |
16.73%
|
June 30, 2024 | USD 12.49 | 0.87% |
|
Japan |
|
23 |
16.73%
|
March 31, 2024 | USD 11.15 | -1.27% |
|
Japan |
|
24 |
16.34%
|
March 31, 2024 | USD 9.15 | -1.97% |
|
Japan |
|
25 |
15.93%
|
March 31, 2024 | USD 19.21 | -1.38% |
|
Japan |
|
26 |
15.82%
|
Aug. 31, 2024 | USD 9.32 | -2.24% |
|
Japan |
|
27 |
15.63%
|
Sept. 30, 2024 | USD 9.46 | -2.05% |
|
Japan |
|
28 |
15.60%
|
March 31, 2024 | USD 27.09 | -1.08% |
|
Japan |
|
29 |
15.55%
|
March 31, 2024 | USD 14.75 | -0.46% |
|
Japan |
|
30 |
15.47%
|
March 31, 2024 | USD 43.36 | -1.17% |
|
Japan |
|
31 |
14.99%
|
March 31, 2024 | USD 29.12 | 0.44% |
|
Japan |
|
32 |
14.91%
|
March 31, 2024 | USD 14.83 | -0.95% |
|
Japan |
|
33 |
14.90%
|
March 31, 2024 | USD 24.26 | -0.77% |
|
Japan |
|
34 |
14.71%
|
March 31, 2024 | USD 4.81 | -0.59% |
|
Japan |
|
35 |
14.23%
|
May 31, 2024 | USD 9.32 | -0.86% |
|
Japan |
|
36 |
13.58%
|
June 30, 2024 | USD 16.87 | -2.21% |
|
Japan |
|
37 |
13.49%
|
March 31, 2024 | USD 10.95 | -0.53% |
|
Japan |
|
38 |
13.08%
|
April 30, 2024 | USD 30.20 | 0.44% |
|
Japan |
|
39 |
13.07%
|
March 31, 2024 | USD 11.36 | -0.42% |
|
Japan |
|
40 |
12.84%
|
May 31, 2024 | USD 46.78 | -2.70% |
|
Japan |
|
41 |
12.65%
|
Feb. 29, 2024 | USD 17.40 | -0.57% |
|
Japan |
|
42 |
12.46%
|
Feb. 29, 2024 | USD 14.39 | -0.85% |
|
Japan |
|
43 |
12.37%
|
Dec. 31, 2023 | USD 9.78 | -1.94% |
|
Japan |
|
44 |
12.19%
|
June 30, 2024 | USD 20.26 | -6.39% |
|
Japan |
|
45 |
11.92%
|
March 31, 2024 | USD 13.76 | -1.19% |
|
Japan |
|
46 |
11.73%
|
May 31, 2024 | USD 61.25 | 0.14% |
|
Japan |
|
47 |
11.56%
|
Feb. 29, 2024 | USD 12.40 | -1.00% |
|
Japan |
|
48 |
11.36%
|
March 31, 2024 | USD 9.47 | -2.44% |
|
Japan |
|
49 |
11.19%
|
Dec. 31, 2023 | USD 13.83 | -0.63% |
|
Japan |
|
50 |
11.03%
|
March 31, 2024 | USD 8.60 | -1.54% |
|
Japan |
The Healthcare company in Japan with the highest Return on Capital Employed (ROCE) is Medical Data Vision Co., Ltd. (Tokyo Stock Exchange: 3902.T) at 39.99%.
The Healthcare company in Japan with the lowest Return on Capital Employed (ROCE) is OncoTherapy Science, Inc. (Tokyo Stock Exchange: 4564.T) at -220.77%.
The top 10 Healthcare companies in Japan by Return on Capital Employed (ROCE) are Medical Data Vision Co., Ltd., Pharma Foods International Co., Ltd., Elan Corporation, Mizuho Medy Co.,Ltd., Kanamic Network Co.,LTD, FINDEX Inc., Chugai Pharmaceutical Co., Ltd., GNI Group Ltd., OPTiM Corporation and Charm Care Corporation.
The bottom 10 Healthcare companies in Japan by Return on Capital Employed (ROCE) are OncoTherapy Science, Inc., Oncolys BioPharma Inc., SanBio Company Limited, Solasia Pharma K.K., Carna Biosciences, Inc., Precision System Science Co., Ltd., MEDINET Co., Ltd., StemRIM, NanoCarrier Co., Ltd. and Data Horizon Corporation.